Ausgabe 3/2020
Inhalt (14 Artikel)
ETMR: a tumor entity in its infancy
Sander Lambo, Katja von Hoff, Andrey Korshunov, Stefan M. Pfister, Marcel Kool
Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
Juan Lantero Rodriguez, Thomas K. Karikari, Marc Suárez-Calvet, Claire Troakes, Andrew King, Andreja Emersic, Dag Aarsland, Abdul Hye, Henrik Zetterberg, Kaj Blennow, Nicholas J. Ashton
Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ
Arne Ittner, Prita Riana Asih, Amanda R. P. Tan, Emmanuel Prikas, Josefine Bertz, Kristie Stefanoska, Yijun Lin, Alexander M. Volkerling, Yazi D. Ke, Fabien Delerue, Lars M. Ittner
miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease
Ben Readhead, Jean-Vianney Haure-Mirande, Diego Mastroeni, Mickael Audrain, Tomas Fanutza, Soong H. Kim, Robert D. Blitzer, Sam Gandy, Joel T. Dudley, Michelle E. Ehrlich
SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease
Neelam Younas, Saima Zafar, Mohsin Shafiq, Aneeqa Noor, Anna Siegert, Amandeep Singh Arora, Alexey Galkin, Ayesha Zafar, Mathias Schmitz, Christine Stadelmann, Olivier Andreoletti, Isidre Ferrer, Inga Zerr
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease
S. Bandres-Ciga, S. Saez-Atienzar, J. J. Kim, M. B. Makarious, F. Faghri, M. Diez-Fairen, H. Iwaki, H. Leonard, J. Botia, M. Ryten, D. Hernandez, J. R. Gibbs, J. Ding, Z. Gan-Or, A. Noyce, L. Pihlstrom, A. Torkamani, A. R. Soltis, C. L. Dalgard, S. W. Scholz, B. J. Traynor, D. Ehrlich, C. R. Scherzer, M. Bookman, M. Cookson, C. Blauwendraat, M. A. Nalls, A. B. Singleton
Lesion stage-dependent causes for impaired remyelination in MS
Katharina Heß, Laura Starost, Nicholas W. Kieran, Christian Thomas, Maria C. J. Vincenten, Jack Antel, Gianvito Martino, Inge Huitinga, Luke Healy, Tanja Kuhlmann
The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment
Yan Ting Liu, Fang Liu, Lei Cao, Li Xue, Wei Ting Gu, Yong Zhi Zheng, Hao Tang, Yu Wang, Hong Yao, Yong Zhang, Wan Qun Xie, Bo Han Ren, Zhuo Hui Xiao, Ying Jie Nie, Ronggui Hu, Zhe Bao Wu
Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19
Zane Jaunmuktane, Ula Mahadeva, Anna Green, Vivek Sekhawat, Nicholas A. Barrett, Lucy Childs, Manu Shankar-Hari, Maria Thom, Hans Rolf Jäger, Sebastian Brandner
ATP10B and the risk for Parkinson’s disease
Raquel Real, Anni Moore, Cornelis Blauwendraat, Huw R. Morris, Sara Bandres-Ciga
Reply: ATP10B and the risk for Parkinson’s disease
Stefanie Smolders, Christine Van Broeckhoven
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort
Stephanie T. Jünger, Felipe Andreiuolo, Martin Mynarek, Inken Wohlers, Sven Rahmann, Ludger Klein-Hitpass, Evelyn Dörner, Anja zur Mühlen, Natalia Velez-Char, Katja von Hoff, Monika Warmuth-Metz, Rolf-Dieter Kortmann, Beate Timmermann, Andre von Bueren, Stefan Rutkowski, Torsten Pietsch
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Philipp Sievers, Thomas Hielscher, Daniel Schrimpf, Damian Stichel, David E. Reuss, Anna S. Berghoff, Marian C. Neidert, Hans-Georg Wirsching, Christian Mawrin, Ralf Ketter, Werner Paulus, Guido Reifenberger, Katrin Lamszus, Manfred Westphal, Nima Etminan, Miriam Ratliff, Christel Herold-Mende, Stefan M. Pfister, David T. W. Jones, Michael Weller, Patrick N. Harter, Wolfgang Wick, Matthias Preusser, Andreas von Deimling, Felix Sahm
Correction to: Somatic mutations in neurons during aging and neurodegeneration
Bert M. Verheijen, Marc Vermulst, Fred W. van Leeuwen